FI104180B1 - Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi - Google Patents
Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksiInfo
- Publication number
- FI104180B1 FI104180B1 FI922847A FI922847A FI104180B1 FI 104180 B1 FI104180 B1 FI 104180B1 FI 922847 A FI922847 A FI 922847A FI 922847 A FI922847 A FI 922847A FI 104180 B1 FI104180 B1 FI 104180B1
- Authority
- FI
- Finland
- Prior art keywords
- binding
- antibody
- antagonists
- polypeptide
- management
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/247—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45357089A | 1989-12-20 | 1989-12-20 | |
US45357089 | 1989-12-20 | ||
US9007289 | 1990-12-18 | ||
PCT/US1990/007289 WO1991009059A1 (en) | 1989-12-20 | 1990-12-18 | Antibody antagonists of human interleukin-4 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI922847A FI922847A (fi) | 1992-06-18 |
FI922847A0 FI922847A0 (fi) | 1992-06-18 |
FI104180B FI104180B (fi) | 1999-11-30 |
FI104180B1 true FI104180B1 (fi) | 1999-11-30 |
Family
ID=23801108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI922847A FI104180B1 (fi) | 1989-12-20 | 1992-06-18 | Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi |
Country Status (26)
Country | Link |
---|---|
US (1) | US6358509B1 (fi) |
EP (1) | EP0506826B1 (fi) |
JP (1) | JPH0730116B2 (fi) |
KR (1) | KR960016862B1 (fi) |
AT (1) | ATE136906T1 (fi) |
AU (1) | AU639754B2 (fi) |
CA (1) | CA2071908C (fi) |
CZ (1) | CZ283050B6 (fi) |
DE (1) | DE69026627T2 (fi) |
DK (1) | DK0506826T3 (fi) |
ES (1) | ES2085983T3 (fi) |
FI (1) | FI104180B1 (fi) |
GR (1) | GR3020325T3 (fi) |
HU (1) | HU215245B (fi) |
IE (1) | IE74708B1 (fi) |
IL (1) | IL96714A0 (fi) |
MX (1) | MX9203401A (fi) |
MY (1) | MY106507A (fi) |
NO (1) | NO922457L (fi) |
NZ (1) | NZ236511A (fi) |
OA (1) | OA09704A (fi) |
PT (1) | PT96230B (fi) |
SK (1) | SK279933B6 (fi) |
TW (1) | TW221675B (fi) |
WO (1) | WO1991009059A1 (fi) |
ZA (1) | ZA9010190B (fi) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714146A (en) * | 1992-08-26 | 1998-02-03 | Board Of Regents Of The University Of Washington | IL-4 bone therapy |
KR100398819B1 (ko) | 1993-09-02 | 2004-02-05 | 트러스티스 오브 다트마우스 칼리지 | gp39길항제를포함하는약제조성물 |
US5914110A (en) * | 1993-09-07 | 1999-06-22 | Smithkline Beecham Corporation | Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
US5928904A (en) * | 1993-09-07 | 1999-07-27 | Smithkline Beecham Corporation | DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
HU222041B1 (hu) * | 1993-09-07 | 2003-04-28 | Smithkline Beecham Corporation | Az IL4 által kőzvetített rendellenességek kezelésére használható rekombináns 1L4 antitestek, eljárás ezek előállítására, alkalmazására és az őket tartalmazó gyógyszerkészítmények |
US20020193575A1 (en) | 1993-09-07 | 2002-12-19 | Smithkline Beecham P.L.C. | Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
US5597710A (en) * | 1994-03-10 | 1997-01-28 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
US5705154A (en) * | 1995-03-08 | 1998-01-06 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
CA2252790A1 (en) * | 1997-02-28 | 1998-09-03 | Enzo Therapeutics, Inc. | Novel processes implementing selective immune down regulation (sidr) |
US7553487B2 (en) | 1998-12-14 | 2009-06-30 | Genetics Institute, Llc | Method and compositions for treating asthma |
US7507706B1 (en) | 1998-12-14 | 2009-03-24 | Genetics Institute, Llc | Cytokine receptor chain |
EP1142961B1 (en) * | 2000-04-06 | 2008-08-06 | FUJIFILM Corporation | Dye complex and optical information recording medium |
AU2001272925A1 (en) | 2000-05-26 | 2001-12-11 | Immunex Corporation | Use of interleukin-4 antagonists and compositions thereof |
US20020076409A1 (en) * | 2000-07-12 | 2002-06-20 | March Carl J. | Method for treating cancer |
US20030170258A1 (en) * | 2001-05-09 | 2003-09-11 | Enzo Therapeutics, Inc. | Novel processes implementing selective immune down regulation (SIDR) |
FR2838444B1 (fr) | 2002-04-10 | 2016-01-01 | Neovacs | Nouveaux peptides et leur application en therapeutique |
US20070104710A1 (en) * | 2002-06-28 | 2007-05-10 | Domants Limited | Ligand that has binding specificity for IL-4 and/or IL-13 |
WO2004003156A2 (en) * | 2002-07-01 | 2004-01-08 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Il-21 as a regulator of immunoglobin production |
US20110223168A1 (en) * | 2002-12-27 | 2011-09-15 | Greg Winter | Ligand that has binding specificity for il-4 and/or il-13 |
WO2004096849A2 (en) * | 2003-04-25 | 2004-11-11 | University Of Manitoba | Peptide-based cytokine/chemokine vaccines against allergy |
AU2004290017B2 (en) | 2003-11-07 | 2012-05-03 | Immunex Corporation | Antibodies that bind interleukin-4 receptor |
SG10201900535UA (en) | 2003-12-23 | 2019-02-27 | Genentech Inc | Novel anti-il 13 antibodies and uses thereof |
US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
AR050044A1 (es) * | 2004-08-03 | 2006-09-20 | Novartis Ag | Anticuerpo especifico de il-4 |
AU2009316076B2 (en) * | 2008-11-17 | 2015-11-19 | Kobenhavns Universitet | IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
ES2617777T5 (es) | 2010-04-23 | 2022-10-13 | Hoffmann La Roche | Producción de proteínas heteromultiméricas |
US10689447B2 (en) | 2011-02-04 | 2020-06-23 | Genentech, Inc. | Fc variants and methods for their production |
WO2012106587A1 (en) | 2011-02-04 | 2012-08-09 | Genentech, Inc. | Fc VARIANTS AND METHODS FOR THEIR PRODUCTION |
RU2015141529A (ru) * | 2013-04-05 | 2017-05-15 | Дженентек, Инк. | Антитела и биспецифические антитела к il-4 и их применение |
CA2920686C (en) | 2013-09-13 | 2022-12-06 | Genentech, Inc. | Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products |
SG11201601823TA (en) | 2013-09-13 | 2016-04-28 | Genentech Inc | Methods and compositions comprising purified recombinant polypeptides |
KR102603417B1 (ko) | 2014-05-06 | 2023-11-20 | 제넨테크, 인크. | 포유동물 세포를 사용한 이종다량체 단백질의 생산 |
RU2758092C1 (ru) * | 2018-02-01 | 2021-10-26 | Бэйцзин Кавин Текнолоджи Шеа-Холдинг Ко., Лтд. | АНТИТЕЛО К IL-4Rα И ЕГО ПРИМЕНЕНИЕ |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5013824A (en) * | 1985-11-19 | 1991-05-07 | Schering Corporation | Human interleukin-4 peptides and conjugates thereof |
IL80678A (en) * | 1985-11-19 | 1999-05-09 | Schering Biotech Corp | Human interleukin-4 |
US5041381A (en) * | 1986-07-03 | 1991-08-20 | Schering Corporation | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
ZA872781B (en) | 1986-05-19 | 1987-10-05 | Immunology Ventures | B-cell stimulating factor |
EP0327283B1 (en) * | 1988-02-02 | 1993-08-18 | Schering Biotech Corporation | Method of reducing immunoglobulin e responses |
-
1990
- 1990-12-18 ES ES91902038T patent/ES2085983T3/es not_active Expired - Lifetime
- 1990-12-18 ZA ZA9010190A patent/ZA9010190B/xx unknown
- 1990-12-18 NZ NZ236511A patent/NZ236511A/xx unknown
- 1990-12-18 PT PT96230A patent/PT96230B/pt not_active IP Right Cessation
- 1990-12-18 DK DK91902038.8T patent/DK0506826T3/da active
- 1990-12-18 KR KR1019920701458A patent/KR960016862B1/ko not_active IP Right Cessation
- 1990-12-18 AU AU71762/91A patent/AU639754B2/en not_active Ceased
- 1990-12-18 HU HU9202073A patent/HU215245B/hu not_active IP Right Cessation
- 1990-12-18 EP EP91902038A patent/EP0506826B1/en not_active Expired - Lifetime
- 1990-12-18 WO PCT/US1990/007289 patent/WO1991009059A1/en active IP Right Grant
- 1990-12-18 CZ CS906352A patent/CZ283050B6/cs not_active IP Right Cessation
- 1990-12-18 AT AT91902038T patent/ATE136906T1/de not_active IP Right Cessation
- 1990-12-18 JP JP3502759A patent/JPH0730116B2/ja not_active Expired - Fee Related
- 1990-12-18 CA CA002071908A patent/CA2071908C/en not_active Expired - Fee Related
- 1990-12-18 IL IL96714A patent/IL96714A0/xx unknown
- 1990-12-18 SK SK6352-90A patent/SK279933B6/sk unknown
- 1990-12-18 MX MX9203401A patent/MX9203401A/es unknown
- 1990-12-18 DE DE69026627T patent/DE69026627T2/de not_active Expired - Fee Related
- 1990-12-19 IE IE458990A patent/IE74708B1/en not_active IP Right Cessation
- 1990-12-19 MY MYPI90002208A patent/MY106507A/en unknown
- 1990-12-19 TW TW079110658A patent/TW221675B/zh active
-
1992
- 1992-06-18 FI FI922847A patent/FI104180B1/fi active
- 1992-06-19 OA OA60233A patent/OA09704A/en unknown
- 1992-06-19 NO NO92922457A patent/NO922457L/no not_active Application Discontinuation
-
1994
- 1994-07-07 US US08/271,539 patent/US6358509B1/en not_active Expired - Fee Related
-
1996
- 1996-06-24 GR GR960401694T patent/GR3020325T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI104180B1 (fi) | Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi | |
DK0760857T3 (da) | Receptor for onkostatin M | |
DK0931092T3 (da) | Varianter af vækstfaktor for vaskulære endotelceller med antagonistiske egenskaber | |
ATE117375T1 (de) | Transduktionsveränderte fibroblasten und ihre anwendung. | |
DE69434538D1 (de) | Vaskularer endothelialer wachstumsfaktor 2 | |
DE69232952D1 (de) | Antikörper der Rezeptoren von pluripotenten hämatopoetischen Stammzellen flk-1 | |
LU91116I2 (en) | cetuximab | |
DE68918867D1 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
IL100343A0 (en) | G protein coupled glutamate receptors | |
ATE272116T1 (de) | Polypeptide mit der möglichkeit rhesus d antigenspezifische bindungsstrukturen aus zu bilden, dafür kodierende dna und deren prozess der herstellung und anwendung | |
DE69115917D1 (de) | Humane gammainterferonantagonisten | |
DE3867537D1 (de) | Mischung von monoklonalen antikoerpern zur bestimmung der creatinkinaseaktivitaet. | |
ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
GR1000876B (el) | Νεα πολυπεπτιδια που δρουν ως παραγοντες αναπτυξης και αλληλουχιες νουκλεινικων οξεων που κωδικοποιοουν τα πολυπεπτιδια |